Beyang Therapeutics
AI-driven drug discovery company using its ExCEED molecular design platform
$30MSeries A
Role not disclosedRV
Root Venture Partners
Activity from announced rounds
Activity in this selectionmitsubishi-electric-corporation-bc47a8d9
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $51M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionCORE Biomedicine
Developing the next generation of precision medicines by going beyond genomics.
$21MSeries A
Role not disclosed